JP2017008001A5 - - Google Patents

Download PDF

Info

Publication number
JP2017008001A5
JP2017008001A5 JP2015127861A JP2015127861A JP2017008001A5 JP 2017008001 A5 JP2017008001 A5 JP 2017008001A5 JP 2015127861 A JP2015127861 A JP 2015127861A JP 2015127861 A JP2015127861 A JP 2015127861A JP 2017008001 A5 JP2017008001 A5 JP 2017008001A5
Authority
JP
Japan
Prior art keywords
composition according
protective composition
retinal protective
vitamin
retinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015127861A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017008001A (ja
JP6646368B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2015127861A priority Critical patent/JP6646368B2/ja
Priority claimed from JP2015127861A external-priority patent/JP6646368B2/ja
Publication of JP2017008001A publication Critical patent/JP2017008001A/ja
Publication of JP2017008001A5 publication Critical patent/JP2017008001A5/ja
Application granted granted Critical
Publication of JP6646368B2 publication Critical patent/JP6646368B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015127861A 2015-06-25 2015-06-25 網膜保護組成物 Active JP6646368B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015127861A JP6646368B2 (ja) 2015-06-25 2015-06-25 網膜保護組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015127861A JP6646368B2 (ja) 2015-06-25 2015-06-25 網膜保護組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019129277A Division JP6736137B2 (ja) 2019-07-11 2019-07-11 網膜保護組成物

Publications (3)

Publication Number Publication Date
JP2017008001A JP2017008001A (ja) 2017-01-12
JP2017008001A5 true JP2017008001A5 (pt) 2019-03-14
JP6646368B2 JP6646368B2 (ja) 2020-02-14

Family

ID=57760779

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015127861A Active JP6646368B2 (ja) 2015-06-25 2015-06-25 網膜保護組成物

Country Status (1)

Country Link
JP (1) JP6646368B2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019019072A (ja) * 2017-07-14 2019-02-07 寿スピリッツ株式会社 網膜保護剤の製造方法および網膜保護剤
JP7231232B2 (ja) * 2020-03-31 2023-03-01 株式会社東洋新薬 経口組成物
CN111440767B (zh) * 2020-04-24 2023-07-21 尚禾粒线体生物科技(深圳)有限公司 一种线粒体保护剂及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2882894B1 (fr) * 2005-03-11 2009-04-03 Larena Sa Composition alimentaire suppletive
US7829126B2 (en) * 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
RU2315612C1 (ru) * 2006-08-29 2008-01-27 Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" Средство для лечения заболеваний глаз
US20100159029A1 (en) * 2008-12-23 2010-06-24 Alcon Research, Ltd. Composition and nutritional supplements for improving ocular health and reducing ocular inflammatory response

Similar Documents

Publication Publication Date Title
PH12018500212A1 (en) 1,3,4-oxadiazole sulfonamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
WO2016064082A3 (ko) 신규한 아미노알킬벤조티아제핀 유도체 및 이의 용도
BR112017027798A2 (pt) compostos de derivado de 1,3,4-oxadiazol sulfamida como inibidor de histona desacetilase 6 e a composição farmacêutica que compreende os mesmos
PH12016501310A1 (en) Pharmaceutical compositions comprising azd9291
WO2013066839A3 (en) Compounds and methods
WO2013066835A3 (en) Compounds and methods
WO2017053868A8 (en) C4-modified oleanolic acid derivatives for inhibition of il-17 and other uses
MY193740A (en) "substituted 2,4 diamino-quinoline as new anticancer agents"
WO2016016380A8 (en) 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
WO2016046260A8 (en) 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds and use as sgrm modulators
HRP20220683T1 (hr) Liječenje parkinsonove bolesti
EP3231436A4 (en) Pharmaceutical composition for prevention or treatment of metabolic disease, comprising bacteroides acidifaciens as effective ingredient
EP4311575A3 (en) Methotrexate for proliferative vitreoretinopathy
JP2017008001A5 (pt)
JP2017014155A5 (pt)
JP2017012144A5 (pt)
WO2016006974A3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
WO2016006975A3 (en) Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof
EP3248603A4 (en) Pharmaceutical composition for prevention, treatment or delay of alzheimer's disease or dementia containing g protein-coupled receptor 19 agent as active ingredient
WO2015001541A3 (en) Pharmaceutical film composition
EA202191683A1 (ru) Средство, содержащее 4-фенилбутират, для профилактики или лечения пресбиопии
WO2016072392A8 (ja) タウ蛋白産生促進剤、タウ蛋白の欠乏に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物
PH12016501205A1 (en) Catecholamine production accelerator, and therapeutic and preventive agent and therapeutic and preventive food composition for diseases caused by catecholamine deficiency
JP2016210757A5 (pt)
WO2016197042A8 (en) Modified or targeted release formulations of linaclotide